GlassScriptPhysician profile
Rodney G Gadson
NPI 1912984691
$2,321.67
in general payments reported to CMS, 2019-2025
16 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.76 · 2020: $176 · 2021: $17.06 · 2022: $1,335 · 2023: $340 · 2024: $162 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.69 |
| Education | $151.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $832.20 | 2022 | |
| Averitas Pharma INC. | $281.06 | 2023-2025 | Qutenza |
| Triad Life Sciences INC. | $194.15 | 2022 | |
| Nevro Corp. | $166.89 | 2022 | |
| Convatec INC. | $165.44 | 2023-2024 | |
| Horizon Therapeutics Plc | $163.46 | 2019-2021 | |
| Djo, LLC | $151.00 | 2024-2025 | Dr Comfort |
| Organogenesis INC. | $107.36 | 2020-2023 | Puraply |
| Kowa Pharmaceuticals America, INC. | $69.63 | 2023 | Seglentis |
| Paratek Pharmaceuticals, INC. | $48.90 | 2022 | |
| Aroa Biosurgery Incorporated | $38.64 | 2020 | |
| Zyla Life Sciences, INC. | $30.95 | 2019 | |
| Grt US Holding, INC. | $27.26 | 2022 | |
| Medtronic, INC. | $18.83 | 2022 | |
| Hydrofera LLC | $14.51 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Gadson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.